secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeward Ltd. (LFWD)
CIK:        0001607962
Form:       8-K
Filed at:   2026-03-25T23:59:59+00:00
Accession:  0001178913-26-001724
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 2.01, 1.01, 3.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud

Lifeward completes acquisition of Oratech Pharma, issues shares and convertible notes
--------------------------------------------------------------------------------

- Lifeward completed acquisition of Oratech Pharma on March 25, 2026, issuing 2,256,476 ordinary shares and pre-funded warrants to Oramed.
- Issued $10,000,000 aggregate principal amount of senior secured convertible notes and warrants in a private placement.
- Directors Dr. John William Poduska and Randel Richner resigned effective March 25, 2026.
- Appointed Nadav Kidron, Miriam Kidron, and Yehuda Reznick as new directors, expanding board from five to eight.
- Entered into a First Amendment and Assignment to assign Oratech Pharma rights to Oratech Ltd.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1607962/000117891326001724/0001178913-26-001724-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1607962/000117891326001724/zk2634956.htm
  HTML page:      https://secwatch.observer/filing/0001178913-26-001724

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer